Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
18,560,538
-
Share change
-
+1,762,126
-
Total reported value
-
$24,870,287
-
Price per share
-
$1.34
-
Number of holders
-
27
-
Value change
-
+$3,148,020
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q3 2025
As of 30 Sep 2025,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,560,538 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, 683 Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, Ikarian Capital, LLC, MORGAN STANLEY, RAYMOND JAMES FINANCIAL INC, ADAGE CAPITAL PARTNERS GP, L.L.C., and MARSHALL WACE, LLP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.